{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:01:53Z","timestamp":1773720113181,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11567-7","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:11:45Z","timestamp":1772194305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rab8a dysregulation in Parkinson\u2019s disease: A convergence of genetic and molecular pathologies"],"prefix":"10.1007","volume":"53","author":[{"given":"Sophie","family":"Schuelke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayur S.","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"9","key":"11567_CR1","first-page":"e91510","volume":"17","author":"A Heineman","year":"2025","unstructured":"Heineman A et al (2025) Challenges and opportunities of early parkinson\u2019s disease biomarkers: \u03b1-Synuclein, Leucine-Rich repeat kinase 2 (LRRK2), DJ-1, and MicroRNAs. Cureus 17(9):e91510","journal-title":"Cureus"},{"issue":"4","key":"11567_CR2","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/cont.0000000000001593","volume":"31","author":"A Rawls","year":"2025","unstructured":"Rawls A, Okun MS (2025) Parkinson disease. Continuum (Minneap Minn) 31(4):930\u2013955","journal-title":"Continuum (Minneap Minn)"},{"issue":"12","key":"11567_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"10","key":"11567_CR4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma RB et al (2018) Validation of the MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov Disord 33(10):1601\u20131608","journal-title":"Mov Disord"},{"issue":"1","key":"11567_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease Epidemiology, Pathology, Genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312","journal-title":"Clin Geriatr Med"},{"key":"11567_CR6","doi-asserted-by":"publisher","first-page":"149975","DOI":"10.1016\/j.brainres.2025.149975","volume":"1868","author":"S Hajare","year":"2025","unstructured":"Hajare S, Kulkarni YA (2025) Parkinson\u2019s disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies. Brain Res 1868:149975","journal-title":"Brain Res"},{"key":"11567_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071006","author":"JO Day","year":"2021","unstructured":"Day JO, Mullin S (2021) The genetics of Parkinson\u2019s disease and implications for clinical practice. Genes. https:\/\/doi.org\/10.3390\/genes12071006","journal-title":"Genes"},{"key":"11567_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fneur.2020.00682","volume":"11","author":"S Lesage","year":"2020","unstructured":"Lesage S et al (2020) Genetic and phenotypic basis of autosomal dominant parkinson\u2019s disease in a large Multi-Center cohort. Front Neurol 11:682","journal-title":"Front Neurol"},{"key":"11567_CR9","doi-asserted-by":"publisher","first-page":"927682","DOI":"10.3389\/fncel.2022.927682","volume":"16","author":"F Zhang","year":"2022","unstructured":"Zhang F et al (2022) The roles of ATP13A2 gene mutations leading to abnormal aggregation of \u03b1-Synuclein in parkinson\u2019s disease. Front Cell Neurosci 16:927682","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"11567_CR10","doi-asserted-by":"publisher","first-page":"e0184262","DOI":"10.1371\/journal.pone.0184262","volume":"12","author":"H-J Park","year":"2017","unstructured":"Park H-J et al (2017) The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome. PLoS ONE 12(9):e0184262","journal-title":"PLoS ONE"},{"key":"11567_CR11","doi-asserted-by":"publisher","first-page":"1415463","DOI":"10.3389\/fneur.2024.1415463","volume":"15","author":"X Jia","year":"2024","unstructured":"Jia X et al (2024) The interplay between gut microbiota and the brain-gut axis in parkinson\u2019s disease treatment. Front Neurol 15:1415463","journal-title":"Front Neurol"},{"issue":"1","key":"11567_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z et al (2021) Fecal microbiota transplantation protects rotenone-induced parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9(1):226","journal-title":"Microbiome"},{"issue":"2","key":"11567_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.stemcr.2024.01.001","volume":"19","author":"A Mamais","year":"2024","unstructured":"Mamais A et al (2024) The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons. Stem Cell Rep 19(2):163\u2013173","journal-title":"Stem Cell Rep"},{"key":"11567_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222112087","author":"J Mart\u00ednez-Men\u00e1rguez","year":"2021","unstructured":"Mart\u00ednez-Men\u00e1rguez J et al (2021) Focus on the small GTPase Rab1: a key player in the pathogenesis of Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222112087","journal-title":"Int J Mol Sci"},{"key":"11567_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.nbd.2014.06.018","volume":"70","author":"G Yin","year":"2014","unstructured":"Yin G et al (2014) \u03b1-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner. Neurobiol Dis 70:149\u2013161","journal-title":"Neurobiol Dis"},{"key":"11567_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123789","author":"C-C Chiu","year":"2025","unstructured":"Chiu C-C et al (2025) Absence of Rab39b-induced macroautophagy impairment increases neurotoxic \u03b1-synuclein and causes degeneration of substantia nigra dopaminergic neurons in mouse model of X-linked Parkinson\u2019s disease. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2025.123789","journal-title":"Life Sci"},{"issue":"15supplement","key":"11567_CR17","first-page":"8","volume":"92","author":"M Parmar","year":"2019","unstructured":"Parmar M et al (2019) Rab GTPase expression changes in \u03b1-Synucleinopathy and tauopathy disorders (P3.8-041). Neurology 92(15supplement):8\u2013041 P3","journal-title":"Neurology"},{"issue":"7","key":"11567_CR18","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.4103\/NRR.NRR-D-23-01543","volume":"20","author":"I Maejima","year":"2025","unstructured":"Maejima I, Sato K (2025) New aspects of a small GTPase RAB35 in brain development and function. Neural Regen Res 20(7):1971\u20131980","journal-title":"Neural Regen Res"},{"issue":"8","key":"11567_CR19","doi-asserted-by":"publisher","first-page":"R471","DOI":"10.1016\/j.cub.2018.02.010","volume":"28","author":"FR Kiral","year":"2018","unstructured":"Kiral FR et al (2018) Rab GTPases and membrane trafficking in neurodegeneration. Curr Biol 28(8):R471\u2013r486","journal-title":"Curr Biol"},{"issue":"22","key":"11567_CR20","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.15252\/embj.201591593","volume":"34","author":"YC Lai","year":"2015","unstructured":"Lai YC et al (2015) Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J 34(22):2840\u20132861","journal-title":"EMBO J"},{"key":"11567_CR21","doi-asserted-by":"crossref","unstructured":"Steger M et al (2017) Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. Elife, 6","DOI":"10.7554\/eLife.31012"},{"issue":"11","key":"11567_CR22","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1042\/BCJ20180248","volume":"475","author":"R Mir","year":"2018","unstructured":"Mir R et al (2018) The parkinson\u2019s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Biochem J 475(11):1861\u20131883","journal-title":"Biochem J"},{"issue":"9","key":"11567_CR23","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1042\/BCJ20190664","volume":"477","author":"S Vieweg","year":"2020","unstructured":"Vieweg S et al (2020) PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at Threonine72. Biochem J 477(9):1651\u20131668","journal-title":"Biochem J"},{"issue":"5","key":"11567_CR24","doi-asserted-by":"publisher","first-page":"REVIEWS3007","DOI":"10.1186\/gb-2001-2-5-reviews3007","volume":"2","author":"H Stenmark","year":"2001","unstructured":"Stenmark H, Olkkonen VM (2001) The Rab GTPase family. Genome Biol 2(5):REVIEWS3007","journal-title":"Genome Biol"},{"key":"11567_CR25","doi-asserted-by":"crossref","unstructured":"McFarland N et al (2020) Rab GTPase proteins in tauopathy. Neurology, 94(15)","DOI":"10.1212\/WNL.94.15_supplement.5236"},{"issue":"1","key":"11567_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1471-4914(01)02227-4","volume":"8","author":"MC Seabra","year":"2002","unstructured":"Seabra MC, Mules EH, Hume AN (2002) Rab GTPases, intracellular traffic and disease. Trends Mol Med 8(1):23\u201330","journal-title":"Trends Mol Med"},{"key":"11567_CR27","doi-asserted-by":"crossref","unstructured":"Kohrs FE et al (2021) Systematic functional analysis of Rab GTPases reveals limits of neuronal robustness to environmental challenges in flies. Elife, 10","DOI":"10.7554\/eLife.59594"},{"issue":"12","key":"11567_CR28","first-page":"6578","volume":"10","author":"P Chavrier","year":"1990","unstructured":"Chavrier P et al (1990) Molecular cloning of YPT1\/Sect.\u00a04-related cDNAs from an epithelial cell line. Mol Cell Biol 10(12):6578\u20136585","journal-title":"Mol Cell Biol"},{"issue":"Pt 6","key":"11567_CR29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1242\/jcs.109.6.1265","volume":"109","author":"J Armstrong","year":"1996","unstructured":"Armstrong J et al (1996) Identification of a novel member of the Rab8 family from the rat basophilic leukaemia cell line, RBL.2H3. J Cell Sci 109(Pt 6):1265\u20131274","journal-title":"J Cell Sci"},{"issue":"9","key":"11567_CR30","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1091\/mbc.e02-03-0143","volume":"13","author":"K Hattula","year":"2002","unstructured":"Hattula K et al (2002) A Rab8-specific GDP\/GTP exchange factor is involved in actin remodeling and polarized membrane transport. Mol Biol Cell 13(9):3268\u20133280","journal-title":"Mol Biol Cell"},{"issue":"10","key":"11567_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/cm.20529","volume":"68","author":"J Per\u00e4nen","year":"2011","unstructured":"Per\u00e4nen J (2011) Rab8 GTPase as a regulator of cell shape. Cytoskeleton 68(10):527\u2013539","journal-title":"Cytoskeleton"},{"issue":"2","key":"11567_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/35052055","volume":"2","author":"M Zerial","year":"2001","unstructured":"Zerial M, McBride H (2001) Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2(2):107\u2013117","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"15_supplement","key":"11567_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.90.15_supplement.P3.049","volume":"90","author":"N McFarland","year":"2018","unstructured":"McFarland N et al (2018) Rab8a protects against alpha-synuclein toxicity in a rat model of Parkinsonism (P3.049). Neurology 90(15_supplement):P3.049","journal-title":"Neurology"},{"issue":"7","key":"11567_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41419-023-05964-0","volume":"14","author":"E Kania","year":"2023","unstructured":"Kania E et al (2023) LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a\/Rab10-dependent manner. Cell Death Dis 14(7):436","journal-title":"Cell Death Dis"},{"issue":"18","key":"11567_CR35","doi-asserted-by":"publisher","first-page":"e104494","DOI":"10.15252\/embj.2020104494","volume":"39","author":"S Herbst","year":"2020","unstructured":"Herbst S et al (2020) LRRK2 activation controls the repair of damaged endomembranes in macrophages. EMBO J 39(18):e104494","journal-title":"EMBO J"},{"key":"11567_CR36","doi-asserted-by":"crossref","unstructured":"Steger M et al (2016) Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases. Elife, 5","DOI":"10.7554\/eLife.12813"},{"issue":"13","key":"11567_CR37","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1074\/jbc.RA118.005008","volume":"294","author":"P Rivero-R\u00edos","year":"2019","unstructured":"Rivero-R\u00edos P et al (2019) The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A. J Biol Chem 294(13):4738\u20134758","journal-title":"J Biol Chem"},{"issue":"1","key":"11567_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12944-018-0684-x","volume":"17","author":"M Yu","year":"2018","unstructured":"Yu M et al (2018) LRRK2 mediated Rab8a phosphorylation promotes lipid storage. Lipids Health Dis 17(1):34","journal-title":"Lipids Health Dis"},{"issue":"4","key":"11567_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","volume":"49","author":"V Ruip\u00e9rez","year":"2010","unstructured":"Ruip\u00e9rez V, Darios F, Davletov B (2010) Alpha-synuclein, lipids and parkinson\u2019s disease. Prog Lipid Res 49(4):420\u2013428","journal-title":"Prog Lipid Res"},{"issue":"8","key":"11567_CR40","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1074\/jbc.M108414200","volume":"277","author":"NB Cole","year":"2002","unstructured":"Cole NB et al (2002) Lipid droplet binding and oligomerization properties of the parkinson\u2019s disease protein alpha-synuclein. J Biol Chem 277(8):6344\u20136352","journal-title":"J Biol Chem"},{"issue":"12","key":"11567_CR41","doi-asserted-by":"publisher","first-page":"e3001480","DOI":"10.1371\/journal.pbio.3001480","volume":"19","author":"A Mamais","year":"2021","unstructured":"Mamais A et al (2021) Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia. PLoS Biol 19(12):e3001480","journal-title":"PLoS Biol"},{"issue":"1","key":"11567_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00989-y","volume":"11","author":"L Vela-Desojo","year":"2025","unstructured":"Vela-Desojo L et al (2025) A new LRRK2 variant in a family with Parkinson\u2019s disease affects binding to RAB8A. NPJ Parkinsons Dis 11(1):154","journal-title":"NPJ Parkinsons Dis"},{"issue":"50","key":"11567_CR43","doi-asserted-by":"publisher","first-page":"eadj1205","DOI":"10.1126\/sciadv.adj1205","volume":"9","author":"P Pal","year":"2023","unstructured":"Pal P et al (2023) Parkinson\u2019s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B. Sci Adv 9(50):eadj1205","journal-title":"Sci Adv"},{"issue":"6","key":"11567_CR44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/gtc.12583","volume":"23","author":"Y Hashimoto","year":"2018","unstructured":"Hashimoto Y, Shirane M, Nakayama KI (2018) TMEM55B contributes to lysosomal homeostasis and amino acid-induced mTORC1 activation. Genes Cells 23(6):418\u2013434","journal-title":"Genes Cells"},{"issue":"15","key":"11567_CR45","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/hmg\/ddx179","volume":"26","author":"T Inoshita","year":"2017","unstructured":"Inoshita T et al (2017) Vps35 in Cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in drosophila. Hum Mol Genet 26(15):2933\u20132948","journal-title":"Hum Mol Genet"},{"key":"11567_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fnins.2020.00485","volume":"14","author":"CJ Gloeckner","year":"2020","unstructured":"Gloeckner CJ, Porras P (2020) Guilt-by-Association - Functional insights gained from studying the LRRK2 interactome. Front Neurosci 14:485","journal-title":"Front Neurosci"},{"issue":"4","key":"11567_CR47","first-page":"729","volume":"26","author":"MJ Kim","year":"2017","unstructured":"Kim MJ et al (2017) The parkinson\u2019s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking. Hum Mol Genet 26(4):729\u2013741","journal-title":"Hum Mol Genet"},{"issue":"7","key":"11567_CR48","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ng.3589","volume":"48","author":"HX Deng","year":"2016","unstructured":"Deng HX et al (2016) Identification of TMEM230 mutations in Familial parkinson\u2019s disease. Nat Genet 48(7):733\u2013739","journal-title":"Nat Genet"},{"issue":"2","key":"11567_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/19768354.2018.1453545","volume":"22","author":"D Nam","year":"2018","unstructured":"Nam D et al (2018) Characterization of parkinson\u2019s disease-related pathogenic TMEM230 mutants. Anim Cells Syst (Seoul) 22(2):140\u2013147","journal-title":"Anim Cells Syst (Seoul)"},{"issue":"5","key":"11567_CR50","doi-asserted-by":"publisher","first-page":"e2412029122","DOI":"10.1073\/pnas.2412029122","volume":"122","author":"E Bagnoli","year":"2025","unstructured":"Bagnoli E et al (2025) Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain. Proc Natl Acad Sci U S A 122(5):e2412029122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"11567_CR51","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1073\/pnas.1018823108","volume":"108","author":"CJ Westlake","year":"2011","unstructured":"Westlake CJ et al (2011) Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosome. Proc Natl Acad Sci U S A 108(7):2759\u20132764","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"11567_CR52","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1093\/hmg\/ddz201","volume":"28","author":"AJ Lara Ord\u00f3nez","year":"2019","unstructured":"Lara Ord\u00f3nez AJ et al (2019) RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits. Hum Mol Genet 28(21):3552\u20133568","journal-title":"Hum Mol Genet"},{"issue":"19","key":"11567_CR53","doi-asserted-by":"publisher","first-page":"15602","DOI":"10.1074\/jbc.M111.333245","volume":"287","author":"S Feng","year":"2012","unstructured":"Feng S et al (2012) A Rab8 guanine nucleotide exchange factor-effector interaction network regulates primary ciliogenesis. J Biol Chem 287(19):15602\u201315609","journal-title":"J Biol Chem"},{"key":"11567_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fnmol.2018.00417","volume":"11","author":"J Madero-P\u00e9rez","year":"2018","unstructured":"Madero-P\u00e9rez J et al (2018) RAB7L1-Mediated relocalization of LRRK2 to the golgi complex causes centrosomal deficits via RAB8A. Front Mol Neurosci 11:417","journal-title":"Front Mol Neurosci"},{"issue":"23","key":"11567_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt2050","volume":"11","author":"ND Raig","year":"2025","unstructured":"Raig ND et al (2025) Type II kinase inhibitors that target Parkinson\u2019s disease\u2013associated LRRK2. Sci Adv 11(23):eadt2050","journal-title":"Sci Adv"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11567-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:03:19Z","timestamp":1772197399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11567-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11567"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11567-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any conflicts of interest to disclose","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No consent is needed, as the study did not involve human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No consent is needed, as this manuscript contains no personal data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"To refine the final written draft of the article, the author(s) utilized artificial intelligence (AI) software, such as Gemini, solely for identifying and correcting grammatical errors and enhancing the overall readability of the final draft. After using this tool\/service, the author(s) reviewed and edited the content as needed and take (s) full responsibility for the content of the publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial\u00a0intelligence (AI) software\u00a0"}}],"article-number":"443"}}